Three Weeks of Treatment Induced Long-term Remission in a Patient with Micrococcus luteus-related Peritonitis

Intern Med. 2023 Jun 1;62(11):1631-1633. doi: 10.2169/internalmedicine.0340-22. Epub 2022 Oct 19.

Abstract

Micrococcus luteus can cause relapsing and refractory peritoneal dialysis infection because it leads to strong biofilm formation. A 69-year-old woman who had undergone peritoneal dialysis (PD) visited the emergency department complaining of cloudy peritoneal dialysate. She was initially given intraperitoneal cefazolin (1 g/day) and ceftazidime (1 g/day). Micrococcus luteus was detected in a culture test. Thus, ceftazidime was discontinued. She remained disease-free for 22 months until she developed PD-related peritonitis. We administered antibiotics for 21 days and thereafter identified 2 important clinical issues. Micrococcus species-related peritonitis can sometimes be cured without vancomycin. Furthermore, the provision of three weeks of sufficient treatment may be important.

Keywords: Micrococcus luteus; Micrococcus species; peritoneal dialysis; peritonitis.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Ceftazidime* / therapeutic use
  • Female
  • Humans
  • Micrococcus luteus
  • Peritonitis* / drug therapy
  • Peritonitis* / etiology
  • Vancomycin / therapeutic use

Substances

  • Ceftazidime
  • Anti-Bacterial Agents
  • Vancomycin